Psychosomatic disorders in patients with allergodermatoses and their correction. E.F. Kutasevich. Dermatology and Venereology. No. 1 (83) 2019.
Stress and nervous-conflict situations in 35.44% of patients with allergodermatosis caused clinical manifestations of the disease. The use in the complex treatment of patients with allergic dermatitis antidepressant drug Miaser containing myanserine hydrochloride, reduces the itching intensity and its earlier relief and earlier onset of regression of psychosomatic disorders. Thus, Miasser (myanserine hydrochloride) has an effect not only on depressive anxiety disorders, mood and sleep disorders, but also on the presence and intensity of itching. Miasser containing myanserine hydrochloride at a dose of 10 mg per day per night should be used in the treatment of patients with allergodermatosis.